InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（4 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
4
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Mayo Stephen, Directeur. Officer active across 2 companies, notably Sarepta Therapeutics, Inc.. In total, 10 reports have been recorded. Breakdown: 0 buy · 4 sells. Total volume traded: €592k. History available since 16 November 2021. The latest transaction was filed on 12 March 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Mayo Stephen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
7,239 股@ US$17.0219.3% 占其流量Common StockSEC:0001193125-26-106701:0
2,383 股Common StockSEC:0000950170-25-037525:0
3,135 股@ US$122.9679.7% 占其流量Common StockSEC:0000950170-24-027497:0
1,846 股0Common StockSEC:0000950170-24-026614:0
10,000 股@ US$4.2855100.0% 占其流量Common StockSEC:0001593968-23-001153:0
1,523 股0Common StockSEC:0001209191-23-017394:0
858 股@ US$109.9220.3% 占其流量Common StockSEC:0001209191-22-058283:0
35,328 股0Common StockSEC:0001737287-22-000053:0
2,953 股0Common StockSEC:0001209191-22-017713:0
4,292 股0Common StockSEC:0001209191-21-065315:0
10 条申报中的 10 条
About Mayo Stephen
Mayo Stephen is Director at Sarepta Therapeutics, Inc. and Allogene Therapeutics, Inc. The record shows 10 filings in total, and across the 10 sampled recent filings the transactions are all sales, totaling EUR 591523, from 2021-11-17 to 2026-03-13. The most common transaction nature is Attribution.
